RD Medicine

Glomerulonephritis: How To Use Complement, Serology, And The Clinical Pattern

USMLE
RD Medicine - USMLE

RD Medicine - USMLE

NOVEMBER 16, 2026
Glomerulonephritis: How To Use Complement, Serology, And The Clinical Pattern

Glomerulonephritis describes inflammatory injury involving the glomeruli. Patients may present with hematuria, proteinuria, hypertension, edema, reduced kidney function, or a rapidly progressive nephritic syndrome.

The most efficient approach is not to memorize every disease individually. Begin with the urine sediment, complement level, serology, systemic manifestations, and speed of kidney function decline.

Recognize The Nephritic Pattern

Common findings include:

  • Glomerular hematuria
  • Dysmorphic red blood cells
  • Red blood cell casts
  • Variable proteinuria
  • Hypertension
  • Edema
  • Increased creatinine

The absence of a red blood cell cast does not exclude glomerulonephritis. Urine microscopy quality and timing matter.

Determine The Clinical Urgency

Rapidly progressive glomerulonephritis may cause a substantial decline in kidney function over days to weeks.

Urgent features include:

  • Rapidly rising creatinine
  • Oliguria
  • Hyperkalemia
  • Severe acid-base disturbance
  • Pulmonary hemorrhage
  • Severe hypertension
  • Fluid overload

Serologic testing and kidney biopsy should be coordinated quickly when organ-threatening disease is suspected.

Divide The Differential By Complement

Low Complement

Important possibilities include:

  • Lupus nephritis
  • Infection-related glomerulonephritis
  • Cryoglobulinemic glomerulonephritis
  • Immune-complex membranoproliferative patterns
  • Complement-mediated glomerulopathy

Low complement suggests consumption or dysregulation but does not establish a single diagnosis.

Normal Complement

Important possibilities include:

  • IgA nephropathy
  • ANCA-associated vasculitis
  • Anti-GBM disease
  • Alport syndrome
  • Thin basement membrane disease

Complement is a sorting tool, not a final answer.

Use Serology Purposefully

ANA And Anti-Double-Stranded DNA

These findings may support systemic lupus erythematosus. Low complement, proteinuria, hematuria, and active sediment increase concern for lupus nephritis.

ANCA

PR3-ANCA and MPO-ANCA may support ANCA-associated vasculitis. The clinical pattern may include glomerulonephritis, pulmonary capillaritis, upper-airway disease, neuropathy, skin lesions, or eosinophilic disease.

ANCA results must be interpreted within the clinical context.

Anti-GBM Antibodies

Anti-GBM disease may present with rapidly progressive glomerulonephritis, pulmonary hemorrhage, or both. Because kidney function can deteriorate rapidly, evaluation and treatment are time-sensitive.

Cryoglobulins

Cryoglobulinemic disease may cause glomerulonephritis, purpura, neuropathy, arthralgia, and low complement. Evaluation should include possible infectious, autoimmune, and lymphoproliferative causes.

Infection Testing

Depending on the presentation, testing may include hepatitis B, hepatitis C, HIV, blood cultures, or evaluation for another active infection.

Recognize Pulmonary-Renal Syndromes

The combination of glomerulonephritis and diffuse alveolar hemorrhage is an emergency.

Important causes include:

  • ANCA-associated vasculitis
  • Anti-GBM disease
  • Systemic lupus erythematosus
  • Other severe immune-complex disorders

Hemoptysis may be absent. Falling hemoglobin, new pulmonary infiltrates, hypoxemia, and active urine sediment should raise concern.

Understand The Role Of Kidney Biopsy

Serology suggests a mechanism. Biopsy can define:

  • The pattern of injury
  • Disease activity
  • Chronic irreversible damage
  • Immune deposits
  • Prognostic features
  • Treatment implications

Light microscopy, immunofluorescence, and electron microscopy provide complementary information.

Treatment should not necessarily be delayed when life-threatening pulmonary or renal involvement is strongly suspected.

High-Yield Framework

When glomerulonephritis is suspected:

  1. Confirm the nephritic urine pattern.
  2. Determine how quickly kidney function is changing.
  3. Check complement.
  4. Order serology based on the clinical pattern.
  5. Search for pulmonary and systemic involvement.
  6. Exclude infection and important mimics.
  7. Obtain a kidney biopsy when appropriate.
  8. Begin urgent treatment when organs are threatened.

The laboratory panel does not replace clinical reasoning. Complement and antibodies are most useful when they are connected to the urine sediment, organ pattern, and disease timeline.

References

  1. Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International. 2021.
  2. Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for ANCA-Associated Vasculitis.

Learn more about our school

I want to know more